上海交通大学学报(医学版), 2024, 44(2): 250-257 doi: 10.3969/j.issn.1674-8115.2024.02.011

论著 · 公共卫生

老年人群体质量指数与慢性代谢性疾病的关系

蒋莹,1, 李清瑶,1,2, 陈之琦1, 汪佳璐1, 李云2, 徐仁应,1

1.上海交通大学医学院附属仁济医院临床营养科,上海 200127

2.华北理工大学公共卫生学院预防医学系,唐山 063210

Association between body mass index and chronic metabolic diseases in Chinese aged population

JIANG Ying,1, LI Qingyao,1,2, CHEN Zhiqi1, WANG Jialu1, LI Yun2, XU Renying,1

1.Department of Clinical Nutrition, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200127, China

2.Department of Preventive Medicine, School of Public Health, North China University of Science and Technology, Tangshan 063210, China

通讯作者: 徐仁应,电子信箱:721001735@shsmu.edu.cn

第一联系人: 蒋 莹、李清瑶为本文共同第一作者。

编委: 张慧俊

收稿日期: 2023-08-10   接受日期: 2023-12-06  

Corresponding authors: XU Renying,E-mail:721001735@shsmu.edu.cn.

Received: 2023-08-10   Accepted: 2023-12-06  

作者简介 About authors

蒋 莹(1988—),女,主管营养师,学士;电子信箱:pinksalad@126.com E-mail:pinksalad@126.com

李清瑶(1998—),女,硕士生;电子信箱:gyon071@126.com E-mail:gyon071@126.com

摘要

目的·评估老年人群体质量指数(body mass index,BMI)与慢性代谢性疾病发生风险的关系。方法·以2014—2021年在上海交通大学医学院附属仁济医院体检中心进行体检的老年人(≥60岁)为研究对象。收集其各项生化指标。由经过培训的护士测量其身高、体质量和血压。采用问卷法收集研究对象既往慢性代谢性疾病史。收缩压≥140 mmHg(1 mmHg=0.133 kPa)、舒张压≥90 mmHg或既往有高血压病史,定义为高血压。空腹血糖≥7.0 mmol/L或既往有糖尿病病史,定义为糖尿病。总胆固醇≥6.2 mmol/L、三酰甘油≥2.3 mmol/L或既往有脂代谢异常病史,定义为脂质代谢紊乱。BMI与高血压、糖尿病和脂质代谢紊乱之间的关系采用受试者操作特征(receiver operator characteristic,ROC)曲线和二元Logistic回归进行分析评估。结果·共收集59 083例研究对象的资料,其中男性30 807例,女性28 276例,平均年龄(67.9±6.3)岁。高血压、糖尿病和脂质代谢紊乱的发生率分别为76.5%(45 219/59 083)、24.1%(14 225/59 083)和50.0%(29 544/59 083)。与60~74岁的老年人群相比,75岁及以上的老年人患高血压和糖尿病的比例更高,患脂质代谢紊乱和无代谢异常的比例更低。通过ROC曲线分析,BMI对于高血压、糖尿病和脂质代谢紊乱的切点值分别为24.3、23.9和23.9 kg/m2。老年男性高血压和糖尿病的BMI切点值和老年女性十分接近(高血压BMI切点值:老年男性24.3 kg/m2vs 老年女性24.2 kg/m2;糖尿病BMI切点值:老年男性24.0 kg/m2vs 老年女性23.7 kg/m2),但老年男性脂质代谢紊乱的BMI切点值明显高于老年女性(老年男性24.0 kg/m2vs 老年女性22.5 kg/m2)。60~74岁老年人的BMI对慢性代谢性疾病的切点值(24.2~24.7 kg/m2)高于75岁及以上的老年人(22.9~23.8 kg/m2)。结论·60~74岁老年人群应将BMI控制在24.0 kg/m2以下,而75岁及以上老年人群应将BMI控制在23.0 kg/m2以下,则有利于降低其慢性代谢性疾病的风险。

关键词: 身体质量指数 ; 慢性代谢性疾病 ; 老年人

Abstract

Objective ·To evaluate the relationship between body mass index (BMI) and chronic metabolic diseases. Methods ·The elderly (≥60 years old) who were underwent physical examination in the Physical Examination Center of Renji Hospital, Shanghai Jiao Tong University School of Medicine from 2014 to 2021 were studied. Their results of biochemical indicators were collected. Their height, body weight, and blood pressure were measured by trained nurses. The history of chronic metabolic diseases was collected by self-reported questionnaire. Systolic blood pressure ≥140 mmHg (1 mmHg=0.133 kPa), diastolic blood pressure ≥90 mmHg, or self-reported hypertension history was defined as hypertension. Fasting blood glucose ≥7.0 mmol/L or self-reported history of diabetes was defined as diabetes. Total cholesterol≥6.2 mmol/L, triglyceride≥2.3 mmol/L, or self-reported history of dyslipidemia was defined as dyslipidemia. The relationship between BMI and hypertension, diabetes, and dyslipidemia was evaluated by using receiver operator characteristic (ROC) curve analysis and binary logistic regression. Results ·Data of 59 083 subjects were collected [30 807 men and 28 276 women, average age: (67.9±6.3) years old]. The prevalence of hypertension, diabetes and dyslipidemia was 76.5% (45 219/59 083), 24.1% (14 225/59 083) and 50.0% (29 544/59 083), respectively. Compared to the elderly people aged 60‒74 years, those aged 75 years and above had a higher proportion of hypertension and diabetes, and a lower proportion of dyslipidemia and no metabolic abnormalities. With ROC analysis, the BMI cut-off values for hypertension, diabetes, and dyslipidemia were 24.3, 23.9, and 23.9 kg/m2. The BMI cut-off values for hypertension and diabetes in elderly men were similar to those in elderly women (for hypertension: 24.3 kg/m2 in elderly men vs 24.2 kg/m2 in elderly women; for diabetes: 24.0 kg/m2 in elderly men vs 23.7 kg/m2 in elderly women); however, BMI cut-off value for dyslipidemia was obviously higher in elderly men than that in elderly women (24.0 kg/m2 in elderly men vs 22.5 kg/m2 in elderly women). The BMI cut-off value for chronic metabolic diseases was higher in the elderly people aged 60‒74 years than that in the elderly people aged 75 years and above (24.2‒24.7 kg/m2vs 22.9‒23.8 kg/m2). Conclusion ·Elderly people aged 60‒74 years should maintain the BMI below 24.0 kg/m2, while those aged 75 years and above should aim for the BMI below 23.0 kg/m2, so as to reduce the risk of chronic metabolic diseases.

Keywords: body mass index (BMI) ; chronic metabolic disease ; elderly

PDF (1681KB) 元数据 多维度评价 相关文章 导出 EndNote| Ris| Bibtex  收藏本文

本文引用格式

蒋莹, 李清瑶, 陈之琦, 汪佳璐, 李云, 徐仁应. 老年人群体质量指数与慢性代谢性疾病的关系. 上海交通大学学报(医学版)[J], 2024, 44(2): 250-257 doi:10.3969/j.issn.1674-8115.2024.02.011

JIANG Ying, LI Qingyao, CHEN Zhiqi, WANG Jialu, LI Yun, XU Renying. Association between body mass index and chronic metabolic diseases in Chinese aged population. Journal of Shanghai Jiao Tong University (Medical Science)[J], 2024, 44(2): 250-257 doi:10.3969/j.issn.1674-8115.2024.02.011

人口老龄化是中国乃至全球最大的卫生与社会人口问题。世界卫生组织统计,2020年全世界65岁及以上的老年人有7.27亿。全国性的研究报告显示在中国,老年人群肥胖相关的代谢性疾病仍是一个重大的公共卫生问题1-2

体质量指数(body mass index,BMI)是一个被广泛应用且简便易行的评估肥胖及其相关慢性疾病风险的指标。中国成年人群BMI超重和肥胖的切点值分别为24.0和28.0 kg/m2[3。超过这个切点值,则高血压、糖尿病、脂质代谢紊乱的风险大大增加4-6。但老年人群适宜的BMI切点值还存在很大争议。中国营养学会2022年发布的膳食指南7将中国老年人群的BMI范围定为20.0~26.9 kg/m2,但该范围并未考虑不同年龄老年人群的差异。难以确定老年人BMI切点值的原因在于老年患者可能存在“肥胖悖论(obesity paradox)”8:高龄老年人群中低体质量与较高的死亡风险相关,而超重则与较低的死亡风险相关9。英国的一项研究10发现超重和肥胖与年轻人和中年人慢性疾病风险和死亡率呈显著正相关,但在老年人群中BMI和总死亡率呈现“J”型关联。但也有大样本研究11n=126 123)显示在正常范围内BMI降低可以降低老年人高血压的风险。由于年龄相关的身体成分变化,比如体脂肪再分布和老年人肌肉质量下降等差异12-14,可能会导致老年人在相同BMI下具有与一般成年人不同的患病和死亡风险。本研究拟探讨老年人群适宜的BMI切点值,以期为更好地促进健康老龄化、降低其慢性疾病的发生风险提供参考。

1 对象与方法

1.1 研究对象

收集2014—2021年在上海交通大学医学院附属仁济医院体检中心进行体检的老年人群为研究对象。纳入标准:年龄≥60周岁。排除标准:①身高和体质量数据缺失。②血压值缺失。③生化检验数据缺失。④既往明确诊断恶性肿瘤15。⑤既往存在慢性肾脏疾病且估算的肾小球滤过率(estimated glomerular filtration rate,eGFR)<60 mL/(min·1.73 m216-18。从体检报告获得研究对象年龄和性别,并进一步根据年龄将研究对象分为2组:60~74岁组和75岁及以上组。

1.2 研究方法

1.2.1 生化指标

所有检测均在我院检验科完成。所有研究对象均禁食≥8 h。空腹采静脉血检测以下指标:空腹血糖(fasting blood glucose,FBG)、总胆固醇(total cholesterol,TC)、三酰甘油(triacylglycerol,TAG)、天冬氨酸转氨酶(aspartate aminotransferase,AST)和丙氨酸转氨酶(alanine aminotransferase,ALT)(Cobasc 701生化分析仪,瑞士罗氏)。eGFR采用慢性肾脏病流行病学协作组(chronic kidney disease epidemiology collaboration,CKD-EPI)发布的2009年CKD-EPI血清肌酐(serum creatinine,Scr)方程(CKD-EPI2009Scr19进行计算。

1.2.2 其他指标

老年人脱外衣及鞋袜,取直立位赤足测量身高和体质量,并计算BMI。血压测量前要求研究对象休息至少10 min后,使用自动血压监测器(HBP-9020,日本欧姆龙)测量血压。如果血压高于正常值,休息10 min后重复测量,并记录2次测量的平均值。高血压、糖尿病、脂代谢异常和恶性肿瘤病史通过自我填写的问卷收集。

1.2.3 慢性代谢性疾病诊断标准

FBG≥7.0 mmol/L或自我报告糖尿病病史则定义为糖尿病20。TC≥6.2 mmol/L、TAG≥2.3 mmol/L或自我报告脂代谢异常病史则定义为脂质代谢紊乱21。收缩压(systolic blood pressure,SBP)≥140 mmHg(1 mmHg=0.133 kPa)、舒张压(diastolic blood pressure,DBP)≥90 mmHg或自我报告高血压病史则定义为高血压22

1.3 统计学分析

采用SAS 9.3软件进行分析。符合正态分布的定量资料以x±s表示,组间比较采用方差分析;不符合正态分布的定量资料以Q1Q3)表示,组间比较采用两独立样本非参数检验。定性资料以频数(百分率)表示,组间比较采用卡方检验。采用二元Logistic回归分析BMI与高血压、糖尿病和脂质代谢紊乱之间的关系,通过受试者操作特征(receiver operator characteristic,ROC)曲线的切点值、敏感度、特异度、曲线下面积(area under the curve,AUC)对模型区分结果进行比较。P<0.05表示差异具有统计学意义。

2 结果

2.1 一般情况描述

本研究剔除未测量身高者6 868人、未测量血压者707人、生化检验数据缺失者5 593人、有恶性肿瘤史者220人、有慢性肾脏疾病史者79人,以及估计eGFR <60 mL/(min·1.73m2)者3 372人后,共纳入59 083名老年人。其中,男性30 807名,女性28 276名。患者基线资料详见表1。男性相较于女性年龄更大、身高更高、体质量更重且BMI更高(均P<0.05)。男性的FBG水平也高于女性,但是女性SBP、TC和TAG高于男性(均P=0.000)。

表1   59 083名老年人的一般情况

Tab 1  General information of 59 083 elderly people

Clinical indexTotal (n=59 083)Male (n=30 807)Female (n=28 276)P value
Age/year67.9±6.367.9±6.467.8±6.20.030
Height/cm161.7±8.4167.5±6.0155.4±5.70.000
Body mass/kg64.7±10.769.6±9.959.4±9.00.000
BMI/(kg·m-2)24.7±3.224.8±3.124.6±3.40.000
FBG/(mmol·L-1)5.8±1.65.8±1.65.7±1.50.000
SBP/mmHg139.5±18.4138.8±18.4140.2±18.50.000
DBP/mmHg79.3±10.479.9±10.478.7±10.30.000
TC/(mmol·L-1)5.1±1.04.9±1.05.4±1.00.000
TAG/(mmol·L-1)1.40 (1.01, 1.99)1.36 (0.97, 1.95)1.46 (1.07, 2.04)0.000
ALT/(IU·L-1)22.0±18.522.3±17.121.6±20.00.000
AST/(IU·L-1)23.5±12.423.0±11.424.1±13.30.000
eGFR/[mL·(min·1.73 m2)-1]85.8±11.185.3±11.486.3±10.80.000
Hypertension/n(%)45 219 (76.5)23 137 (75.1)22 082 (78.1)0.000
Diabetes/n(%)14 225 (24.1)7 960 (25.8)6 265 (22.2)0.000
Hyperlipoidemia/n(%)29 544 (50.0)13 266 (43.1)16 278 (57.6)0.000

新窗口打开| 下载CSV


2.2 慢性代谢性疾病的发生率

本研究人群中,高血压、糖尿病和脂质代谢紊乱的发生率分别为76.5%(45 219/59 083)、24.1%(14 225/59 083)和50.0%(29 544/59 083)。与60~74岁的老年人群相比,75岁及以上的老年人群高血压和糖尿病的比例更高,脂质代谢紊乱和无代谢异常的比例更低(均P=0.000,表2)。

表2   各年龄组慢性代谢性疾病的发生率

Tab 2  Incidence of chronic metabolic diseases in different age groups

Clinical index60‒74 years old (n=50 185)≥75 years old (n=8 898)P value
Hypertension/n(%)37 603 (74.9)7 616 (85.6)0.000
Diabetes/n(%)11 811 (23.5)2 414 (27.1)0.000
Hyperlipoidemia/n(%)25 661 (51.1)3 883 (43.6)0.000
No chronic metabolic diseases/n(%)6 195 (12.3)717 (8.1)0.000

新窗口打开| 下载CSV


2.3 BMI切点值与慢性代谢性疾病ROC曲线分析

老年人群BMI对于高血压、糖尿病和脂质代谢紊乱的切点值分别为24.3、23.9和23.9 kg/m2。在诊断高血压和糖尿病时,老年男性和老年女性BMI切点值相差不大;但在诊断脂质代谢紊乱时,老年女性BMI切点值明显低于老年男性。对于不同年龄的老年人而言,60~74岁的老年人在诊断高血压和糖尿病时BMI切点值高于75岁及以上的老年人,而在诊断脂质代谢紊乱时,BMI切点值在不同年龄的老年人之间十分接近(表3)。

表3   老年人群BMI切点值与慢性代谢性疾病的ROC曲线分析

Tab 3  ROC curve analysis of the relationship between BMI cut-off point and chronic metabolic diseases in the elderly

ClassificationBMI cut-off point/(kg·m-2)Sensitivity1-specificityAUCP value
Total (n=59 083)
Hypertension24.30.570.390.620.000
Diabetes23.90.690.550.600.000
Hyperlipoidemia23.90.680.550.580.000
Male (n=30 807)
Hypertension24.30.610.440.610.000
Diabetes24.00.700.570.590.000
Hyperlipoidemia24.00.700.540.610.000
Female (n=28 276)
Hypertension24.20.560.360.630.000
Diabetes23.70.690.550.600.000
Hyperlipoidemia22.50.760.670.560.000
6074 years old (n=50 185)
Hypertension24.50.760.670.630.000
Diabetes24.70.590.450.600.000
Hyperlipoidemia24.20.610.510.570.000
≥75 years old (n=8 898)
Hypertension23.20.660.490.610.000
Diabetes22.90.770.630.600.000
Hyperlipoidemia23.80.650.490.600.000

新窗口打开| 下载CSV


2.4 BMI与高血压、糖尿病及脂质代谢紊乱的风险分析

BMI与高血压、糖尿病及脂质代谢紊乱的风险分析结果如图1所示。二元Logistic回归结果(图1A~C)表明,以BMI在24.0~25.0 kg/m2之间的老年人群为对照,则BMI≥26.0 kg/m2的老年人群发生高血压、糖尿病及脂质代谢紊乱的风险均明显增加。

图1

图1   BMI与慢性代谢性疾病之间的关系

Note:A‒C. Binary Logistic regression results of BMI with hypertension (A), diabetes (B), and hyperlipoidemia (C). The controlled variables included age, gender, ALT, AST, and eGFR. When analyzing the relationship between BMI and hypertension, further control was applied for FBG, TC, and TAG. When analyzing the relationship between BMI and diabetes, further control was applied for SBP, DBP, TC, and TAG. When analyzing the relationship between BMI and hyperlipoidemia, further control was applied for SBP, DBP, and FBG. D‒F. Restricted cubic spline results of BMI with hypertension (D), diabetes (E), and hyperlipoidemia (F). The controlled variables included age and gender, and the reference value for BMI was 24.56 kg/m2.

Fig 1   Relationship between BMI and chronic metabolic diseases


限制性立方样条结果(图1D~F)显示,BMI与慢性代谢性疾病呈线性关系,当BMI分别超过29.0、28.0和28.0 kg/m2时,高血压、糖尿病及脂质代谢紊乱的风险增加均更为显著。

3 讨论

本研究共纳入60岁及以上老年人59 083名。通过ROC曲线分析BMI对于高血压、糖尿病和脂质代谢紊乱的切点值分别为24.3、23.9和23.9 kg/m2。在控制了年龄、性别、ALT、AST、eGFR、FBG、TC、TAG、SBP和DBP这些因素的影响后,发现BMI≥26.0 kg/m2的老年人群发生高血压、糖尿病和脂质代谢紊乱的风险明显增加。

研究23-26表明老年人群中血压和BMI存在独立相关性,结果与成年人群研究27-28类似。一项以中国社区人群为研究对象的研究结果6提示,50岁以上且BMI≥28.0 kg/m2的人群高血压风险显著升高。孟加拉国成年人群研究25显示,年龄和BMI是导致高血压和临界高血压的危险因素。BMI升高还与50岁以上人群患糖尿病的风险显著相关24。BMI≥25.0 kg/m2的成年人群发生糖尿病的风险是正常体质量或体质量不足人群的2倍28。一项来自日本的研究29以40~79岁人群为对象,结果显示与BMI<25.0 kg/m2相比,BMI≥30 kg/m2会增加该人群患糖尿病风险,但BMI对糖尿病发生风险的影响在不同年龄段有所差异:对中年人的影响大于老年人。伊朗的研究30发现BMI升高显著增加血脂异常风险。BMI升高与血脂异常风险之间的相关性在老年人群同样存在31。一项有65 128名参与者的多中心横断面研究32显示,控制体质量可以降低血脂异常的风险,这一点在绝经后女性中尤为显著。

欧洲一项大规模样本研究33显示,30~60岁人群中BMI是高血压、糖尿病和脂质代谢紊乱的主要危险因素。而意大利的横断面研究34显示BMI与高血压的关系因年龄而异,高龄且肥胖者患高血压风险较瘦者低。加拿大的研究35表明随着年龄增长,BMI和代谢风险之间的关联程度有所减弱:BMI和代谢风险之间的关系在年轻和中年人群要强于老年人群。虽然以往研究显示超重和轻度肥胖的老年人群死亡率反而更低(“肥胖悖论”36),但肥胖悖论可能是统计分析过程中无法排除吸烟等混杂因素所致37。通过生活方式干预避免体质量过多增加可以有效降低慢性代谢性疾病发生风险。

老年人适宜的BMI目前尚无统一标准。一项回顾性研究38通过ROC曲线分析老年人群(平均年龄≥77岁)中男性和女性最佳BMI值分别为31.0~32.0 kg/m2和27.0~28.0 kg/m2;BMI<25.0 kg/m2和BMI>35.0 kg/m2老年人的身体活动能力下降的风险更高。一项单中心横断面观察性研究39报道老年人群BMI切点值为27.0 kg/m2。老年人BMI切点值还存在种族差异。美国慢性代谢性疾病的BMI切点值显著高于日本:美国高血压、糖尿病和血脂异常风险增加的切点值分别为27.0、29.0和26.0 kg/m2,而日本高血压、糖尿病和血脂异常风险增加的切点值分别为23.0、23.0和22.0 kg/m2[40

本研究的优点在于样本量较大,并且校正了慢性代谢性疾病相关的风险因素,以控制混杂因素的影响。然而,本研究仍存在一些不足:首先,本研究为横断面研究,可以用来探究BMI和慢性代谢性疾病之间的联系,但不能推断BMI和慢性代谢性疾病之间存在的因果关系。其次,受试者均来源于健康体检人群,可能会导致代表性差。再次,由于与慢性代谢性疾病密切相关的生活方式、饮食和体育活动等因素数据存在缺失,故本研究无法分析这些因素的调整会如何影响BMI和慢性代谢性疾病的关系。最后,本研究的慢性代谢性疾病病史是通过自我报告进行收集,可能存在回忆偏倚。

综上所述,为降低慢性代谢性疾病的发生风险,60~74岁老年人群应将BMI控制在24.0 kg/m2以下,75岁及以上老年人群应将BMI控制在23.0 kg/m2以下。同时,老年人群可通过积极的体育活动、健康的生活方式和营养均衡的饮食,保持适宜体质量,进而降低慢性代谢性疾病的发生风险。

作者贡献声明

蒋莹、李清瑶、陈之琦、李云、徐仁应参与了试验设计,蒋莹、李清瑶、汪佳璐、徐仁应参与了论文的写作和修改。所有作者均阅读并同意了最终稿件的提交。

AUTHOR's CONTRIBUTIONS

The study was designed by JIANG Ying, LI Qingyao, CHEN Zhiqi, LI Yun and XU Renying. The manuscript was drafted and revised by JIANG Ying, LI Qingyao, WANG Jialu and XU Renying. All the authors have read the last version of paper and consented for submission.

利益冲突声明

所有作者声明不存在利益冲突。

COMPETING INTERESTS

All authors disclose no relevant conflict of interests.

参考文献

XIONG Y, ZHANG Y C, ZHANG F X, et al. Prevalence and associated factors of metabolic syndrome in Chinese middle-aged and elderly population: a national cross-sectional study[J]. Aging Male, 2021, 24(1): 148-159.

[本文引用: 1]

GE H S, YANG Z H, LI X Y, et al. The prevalence and associated factors of metabolic syndrome in Chinese aging population[J]. Sci Rep, 2020, 10(1): 20034.

[本文引用: 1]

ZHOU B F, Cooperative Meta-analysis Group of the Working Group on Obesity in China. Predictive values of body mass index and waist circumference for risk factors of certain related diseases in Chinese adults: study on optimal cut-off points of body mass index and waist circumference in Chinese adults[J]. Biomed Environ Sci, 2002, 15(1): 83-96.

[本文引用: 1]

YORKE E, TETTEH J, BOIMA V, et al. High BMI: an important health risk factor among older adults in Ghana[J]. Public Health Nutr, 2021, 24(14): 4522-4529.

[本文引用: 1]

ZHANG W L, HE K, ZHAO H, et al. Association of body mass index and waist circumference with high blood pressure in older adults[J]. BMC Geriatr, 2021, 21(1): 260.

WANG S K, MA W, WANG S M, et al. Obesity and its relationship with hypertension among adults 50 years and older in Jinan, China[J]. PLoS One, 2014, 9(12): e114424.

[本文引用: 2]

中国营养学会. 中国居民膳食指南(2022)[M]. 北京: 人民卫生出版社, 2022.

[本文引用: 1]

Chinese Nutrition Society. Dietary guidelines for Chinese residents (2022)[M]. Beijing: People's Medical Publishing House, 2022.

[本文引用: 1]

BOSELLO O, VANZO A. Obesity paradox and aging[J]. Eat Weight Disord, 2021, 26(1): 27-35.

[本文引用: 1]

WANG J, TAYLOR A W, ZHANG T, et al. Association between body mass index and all-cause mortality among oldest old Chinese[J]. J Nutr Health Aging, 2018, 22(2): 262-268.

[本文引用: 1]

BHASKARAN K, DOS-SANTOS-SILVA I, LEON D A, et al. Association of BMI with overall and cause-specific mortality: a population-based cohort study of 3.6 million adults in the UK[J]. Lancet Diabetes Endocrinol, 2018, 6(12): 944-953.

[本文引用: 1]

JAVED A A, MA J H, ANDERSON L N, et al. Age-appropriate BMI cut-points for cardiometabolic health risk: a cross-sectional analysis of the Canadian Longitudinal Study on Aging[J]. Int J Obes (Lond), 2022, 46(5): 1027-1035.

[本文引用: 1]

KUK J L, SAUNDERS T J, DAVIDSON L E, et al. Age-related changes in total and regional fat distribution[J]. Ageing Res Rev, 2009, 8(4): 339-348.

[本文引用: 1]

JAFARINASABIAN P, INGLIS J E, REILLY W, et al. Aging human body: changes in bone, muscle and body fat with consequent changes in nutrient intake[J]. J Endocrinol, 2017, 234(1): R37-R51.

GRAF C E, KARSEGARD V L, SPOERRI A, et al. Body composition and all-cause mortality in subjects older than 65 y[J]. Am J Clin Nutr, 2015, 101(4): 760-767.

[本文引用: 1]

KAWADA T. Cancer, hypertension and risk for cardiovascular disease[J]. J Hypertens, 2021, 39(10): 2122.

[本文引用: 1]

ANDERS H J, HUBER T B, ISERMANN B, et al. CKD in diabetes: diabetic kidney disease versus nondiabetic kidney disease[J]. Nat Rev Nephrol, 2018, 14(6): 361-377.

[本文引用: 1]

HAGER M R, NARLA A D, TANNOCK L R. Dyslipidemia in patients with chronic kidney disease[J]. Rev Endocr Metab Disord, 2017, 18(1): 29-40.

WOLLEY M J, STOWASSER M. Resistant hypertension and chronic kidney disease: a dangerous liaison[J]. Curr Hypertens Rep, 2016, 18(5): 36.

[本文引用: 1]

Levey A S, Stevens L A, Schmid C H, et al. A new equation to estimate glomerular filtration rate[J]. Ann Intern Med, 2009, 150(9): 604-612.

[本文引用: 1]

中华医学会糖尿病学分会. 中国2型糖尿病防治指南(2020年版)[J]. 中华糖尿病杂志, 2021, 13(4): 315-409.

[本文引用: 1]

Chinese Diabetes Society. Guideline for the prevention and treatment of type 2 diabetes mellitus in China (2020 edition)[J]. Chinese Journal of Diabetes Mellitus, 2021, 13(4): 315-409.

[本文引用: 1]

中国成人血脂异常防治指南修订联合委员会. 中国成人血脂异常防治指南(2016年修订版)[J]. 中华心血管病杂志, 2016, 44(10): 833-853.

[本文引用: 1]

Joint Committee Issued Chinese Guideline for the Management of Dyslipidemia in Adults. 2016 Chinese guideline for the management of dyslipidemia in adults[J]. Chinese Journal of Cardiology, 2016, 44(10): 833-853.

[本文引用: 1]

中国老年医学学会高血压分会, 国家老年疾病临床医学研究中心中国老年心血管病防治联盟. 中国老年高血压管理指南2019[J]. 中国心血管杂志, 2019, 24(1): 1-23

[本文引用: 1]

Hypertension Branch of Chinese Geriatrics Society, National Clinical Research Center for Geriatric Diseases-Chinese Alliance of Geriatric Cardiovascular Disease. 2019 Chinese guidelines for the management of hypertension in the elderly[J]. Chinese Journal of Cardiovascular Medicine, 2019, 24(1):1-23.

[本文引用: 1]

CHEN Y J, LIANG X, ZHENG S S, et al. Association of body fat mass and fat distribution with the incidence of hypertension in a population-based Chinese cohort: a 22-year follow-up[J]. J Am Heart Assoc, 2018, 7(6): e007153.

[本文引用: 1]

BADR H E, SHAH N M, SHAH M A. Obesity among Kuwaitis aged 50 years or older: prevalence, correlates, and comorbidities[J]. Gerontologist, 2013, 53(4): 555-566.

[本文引用: 1]

RAHMAN M, ZAMAN M M, ISLAM J Y, et al. Prevalence, treatment patterns, and risk factors of hypertension and pre-hypertension among Bangladeshi adults[J]. J Hum Hypertens, 2018, 32(5): 334-348.

[本文引用: 1]

HSU C H, LIN J D, HSIEH C H, et al. Adiposity measurements in association with metabolic syndrome in older men have different clinical implications[J]. Nutr Res, 2014, 34(3): 219-225.

[本文引用: 1]

SEOK LEE H, PARK Y M, HAN K, et al. Obesity-related hypertension: findings from the Korea national health and nutrition examination survey 2008‒2010[J]. PLoS One, 2020, 15(4): e0230616.

[本文引用: 1]

DAS S, DEBNATH M, DAS S, et al. Association of overweight and obesity with hypertension, diabetes and comorbidity among adults in Bangladesh: evidence from nationwide Demographic and Health Survey 2017‒2018 data[J]. BMJ Open, 2022, 12(7): e052822.

[本文引用: 2]

SASAI H, SAIRENCHI T, ISO H, et al. Relationship between obesity and incident diabetes in middle-aged and older Japanese adults: the Ibaraki Prefectural Health Study[J]. Mayo Clin Proc, 2010, 85(1): 36-40.

[本文引用: 1]

EBRAHIMI H, EMAMIAN M H, HASHEMI H, et al. Dyslipidemia and its risk factors among urban middle-aged Iranians: a population-based study[J]. Diabetes Metab Syndr, 2016, 10(3): 149-156.

[本文引用: 1]

LIN H Q, WU J Y, CHEN M L, et al. Prevalence of dyslipidemia and prediction of 10-year CVD risk among older adults living in southeast coastal regions in China: a cross-sectional study[J]. Clin Interv Aging, 2019, 14: 1119-1129.

[本文引用: 1]

XI Y F, NIU L W, CAO N, et al. Prevalence of dyslipidemia and associated risk factors among adults aged ≥35 years in Northern China: a cross-sectional study[J]. BMC Public Health, 2020, 20(1): 1068.

[本文引用: 1]

VAN HEMELRIJCK M, ULMER H, NAGEL G, et al. Longitudinal study of body mass index, dyslipidemia, hyperglycemia, and hypertension in 60, 000 men and women in Sweden and Austria[J]. PLoS One, 2018, 13(6): e0197830.

[本文引用: 1]

PIKILIDOU M I, SCUTERI A, MORRELL C, et al. The burden of obesity on blood pressure is reduced in older persons: the SardiNIA study[J]. Obesity, 2013, 21(1): E10-E13.

[本文引用: 1]

CANNING K L, BROWN R E, JAMNIK V K, et al. Relationship between obesity and obesity-related morbidities weakens with aging[J]. J Gerontol A Biol Sci Med Sci, 2014, 69(1): 87-92.

[本文引用: 1]

CHENG F W, GAO X, MITCHELL D C, et al. Metabolic health status and the obesity paradox in older adults[J]. J Nutr Gerontol Geriatr, 2016, 35(3): 161-176.

[本文引用: 1]

BOWMAN K, DELGADO J, HENLEY W E, et al. Obesity in older people with and without conditions associated with weight loss: follow-up of 955, 000 primary care patients[J]. J Gerontol A Biol Sci Med Sci, 2017, 72(2): 203-209.

[本文引用: 1]

KıSKAÇ M, SOYSAL P, SMITH L, et al. What is the optimal body mass index range for older adults?[J]. Ann Geriatr Med Res, 2022, 26(1): 49-57.

[本文引用: 1]

DI RENZO L, ITANI L, GUALTIERI P, et al. New BMI cut-off points for obesity in middle-aged and older adults in clinical nutrition settings in Italy: a cross-sectional study[J]. Nutrients, 2022, 14(22): 4848.

[本文引用: 1]

KUWABARA M, KUWABARA R, NIWA K, et al. Different risk for hypertension, diabetes, dyslipidemia, and hyperuricemia according to level of body mass index in Japanese and American subjects[J]. Nutrients, 2018, 10(8): 1011.

[本文引用: 1]

/